Symbols / IDXX Stock $528.15 -1.08% IDEXX Laboratories, Inc.

Healthcare • Diagnostics & Research • United States • NMS
IDXX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO —
Exch · Country NMS · United States
Market Cap 41.66B
Enterprise Value 43.02B
Income 1.10B
Sales 4.45B
FCF (ttm) 786.84M
Book/sh 20.14
Cash/sh 2.54
Employees 11,000
Insider 10d —
IPO Jun 21, 1991
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 38.81
Forward P/E 32.00
PEG 3.42
P/S 9.37
P/B 26.22
P/C —
EV/EBITDA 27.83
EV/Sales 9.68
Quick Ratio 0.69
Current Ratio 1.12
Debt/Eq 71.04
LT Debt/Eq —
EPS (ttm) 13.61
EPS next Y 16.50
EPS Growth 17.20%
Revenue Growth 14.30%
EPS Gr Q/Q 14.70%
Rev Gr Q/Q —
Earnings (next) 2026-08-03
Earnings (prior) 2026-05-05
ROA 26.46%
ROE 72.91%
ROIC —
Gross Margin 62.05%
Oper. Margin 31.78%
Profit Margin 24.63%
Shs Outstand 78.88M
Shs Float 78.01M
Insider Own 0.69%
Instit Own 96.85%
Short Float 3.02%
Short Ratio 3.81
Short Interest 2.08M
52W High 769.98
vs 52W High -31.41%
52W Low 496.61
vs 52W Low 6.35%
Beta 1.57
Impl. Vol. 53.69%
Rel Volume 0.14
Avg Volume 542.44K
Volume 75.55K
Target (mean) $709.14
Tgt Median $712.50
Tgt Low $470.00
Tgt High $805.00
# Analysts 14
Recom Buy
Prev Close $533.92
Price $528.15
Change -1.08%
About

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$709.14
Mean price target
2. Current target
$528.15
Latest analyst target
3. DCF / Fair value
$179.55
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$528.15
Low
$470.00
High
$805.00
Mean
$709.14

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-28 main UBS Neutral → Neutral $640
2026-04-15 init Citigroup — → Neutral $650
2026-03-31 main Stifel Buy → Buy $675
2026-02-09 main Piper Sandler Neutral → Neutral $750
2026-02-05 main Barclays Overweight → Overweight $800
2026-02-03 main UBS Neutral → Neutral $730
2026-02-03 main BTIG Buy → Buy $800
2025-12-09 init Barclays — → Overweight $850
2025-11-04 main Morgan Stanley Overweight → Overweight $805
2025-11-04 main UBS Neutral → Neutral $750
2025-11-04 main JP Morgan Overweight → Overweight $775
2025-11-04 main BTIG Buy → Buy $830
2025-10-31 up Stifel Hold → Buy $700
2025-10-01 init UBS — → Neutral $720
2025-08-15 main Morgan Stanley Overweight → Overweight $765
2025-08-11 main Piper Sandler Neutral → Neutral $700
2025-08-04 main JP Morgan Overweight → Overweight $675
2025-08-04 main Morgan Stanley Overweight → Overweight $722
2025-07-29 main Morgan Stanley Overweight → Overweight $628
2025-07-17 main Leerink Partners Outperform → Outperform $600
News
RSS: Latest IDXX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-07 PEACOCK KAREN Director — 101 — —
2026-05-07 VANDEBROEK SOPHIE V Director — 257 — —
2026-05-07 KINGSLEY LAWRENCE D Director — 339 — —
2026-05-07 HOOLEY JOSEPH L. Director — 158 — —
2026-05-07 JUNIUS DANIEL M Director — 257 — —
2026-05-07 SZOSTAK MARGARET ANNE Director — 257 — —
2026-04-30 HOOLEY JOSEPH L. Director — 43 $560.80 $24,114
2026-03-03 UNDERBERG SHARON E General Counsel — 197 $505.53 $99,589
2026-03-03 HUNT NIMRATA K Officer — 1,758 $634.57 $1,115,577
2026-02-27 MAZELSKY JONATHAN JAY Chief Executive Officer — 23,523 $141.60 $3,402,551
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
4,303.70
+10.42%
3,897.50
+6.46%
3,660.95
+8.72%
3,367.32
Operating Revenue
4,303.70
+10.42%
3,897.50
+6.46%
3,660.95
+8.72%
3,367.32
Cost Of Revenue
1,644.12
+8.27%
1,518.58
+3.24%
1,470.98
+7.92%
1,362.99
Reconciled Cost Of Revenue
1,644.12
+8.27%
1,518.58
+3.24%
1,470.98
+7.92%
1,362.99
Gross Profit
2,659.58
+11.80%
2,378.93
+8.63%
2,189.97
+9.26%
2,004.34
Operating Expense
1,299.55
+3.91%
1,250.59
+14.43%
1,092.84
-1.15%
1,105.57
Research And Development
251.21
+14.29%
219.79
+15.10%
190.95
-25.06%
254.82
Selling General And Administration
1,048.34
+1.70%
1,030.80
+14.29%
901.89
+6.01%
850.75
Selling And Marketing Expense
643.55
+9.35%
588.51
+3.96%
566.07
+7.92%
524.50
General And Administrative Expense
404.79
-8.48%
442.29
+31.70%
335.82
+2.94%
326.25
Other Gand A
404.79
-8.48%
442.29
+31.70%
335.82
+2.94%
326.25
Total Expenses
2,943.67
+6.30%
2,769.17
+8.01%
2,563.82
+3.86%
2,468.56
Operating Income
1,360.03
+20.53%
1,128.34
+2.84%
1,097.13
+22.07%
898.76
Total Operating Income As Reported
1,360.03
+20.53%
1,128.34
+2.84%
1,097.13
+22.07%
898.76
EBITDA
1,508.22
+18.67%
1,270.97
+4.38%
1,217.66
+20.35%
1,011.73
Normalized EBITDA
1,508.22
+18.67%
1,270.97
+4.38%
1,217.66
+20.35%
1,011.73
Reconciled Depreciation
145.18
+11.73%
129.94
+13.08%
114.91
+2.69%
111.90
EBIT
1,363.04
+19.46%
1,141.04
+3.47%
1,102.76
+22.55%
899.83
Net Income
1,059.46
+19.33%
887.87
+5.07%
845.04
+24.44%
679.09
Pretax Income
1,324.19
+19.31%
1,109.83
+4.59%
1,061.18
+23.40%
859.97
Net Non Operating Interest Income Expense
-35.84
-93.68%
-18.51
+48.53%
-35.95
+7.32%
-38.79
Interest Expense Non Operating
38.85
+24.51%
31.20
-24.95%
41.58
+4.32%
39.86
Net Interest Income
-35.84
-93.68%
-18.51
+48.53%
-35.95
+7.32%
-38.79
Interest Expense
38.85
+24.51%
31.20
-24.95%
41.58
+4.32%
39.86
Interest Income Non Operating
3.01
-76.30%
12.70
+125.60%
5.63
+428.54%
1.06
Interest Income
3.01
-76.30%
12.70
+125.60%
5.63
+428.54%
1.06
Tax Provision
264.73
+19.26%
221.96
+2.70%
216.13
+19.49%
180.88
Tax Rate For Calcs
0.00
+0.00%
0.00
-1.80%
0.00
-3.01%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
1,059.46
+19.33%
887.87
+5.07%
845.04
+24.44%
679.09
Net Income From Continuing Operation Net Minority Interest
1,059.46
+19.33%
887.87
+5.07%
845.04
+24.44%
679.09
Net Income From Continuing And Discontinued Operation
1,059.46
+19.33%
887.87
+5.07%
845.04
+24.44%
679.09
Net Income Continuous Operations
1,059.46
+19.33%
887.87
+5.07%
845.04
+24.44%
679.09
Minority Interests
—
—
0.00
0.00
Normalized Income
1,059.46
+19.33%
887.87
+5.07%
845.04
+24.44%
679.09
Net Income Common Stockholders
1,059.46
+19.33%
887.87
+5.07%
845.04
+24.44%
679.09
Diluted EPS
13.08
+22.59%
10.67
+6.06%
10.06
+25.28%
8.03
Basic EPS
13.17
+22.28%
10.77
+5.90%
10.17
+25.25%
8.12
Basic Average Shares
80.43
-2.47%
82.47
-0.72%
83.07
-0.67%
83.62
Diluted Average Shares
81.03
-2.67%
83.25
-0.87%
83.98
-0.74%
84.60
Diluted NI Availto Com Stockholders
1,059.46
+19.33%
887.87
+5.07%
845.04
+24.44%
679.09
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
3,350.76
+1.74%
3,293.44
+1.03%
3,259.93
+18.68%
2,746.76
Current Assets
1,413.83
+1.00%
1,399.90
-6.38%
1,495.25
+35.75%
1,101.48
Cash Cash Equivalents And Short Term Investments
180.07
-37.53%
288.27
-36.50%
453.93
+303.33%
112.55
Cash And Cash Equivalents
180.07
-37.53%
288.27
-36.50%
453.93
+303.33%
112.55
Receivables
693.19
+23.49%
561.32
+6.00%
529.53
+7.87%
490.90
Accounts Receivable
552.38
+16.64%
473.57
+3.53%
457.44
+14.18%
400.62
Gross Accounts Receivable
563.68
+15.95%
486.16
+4.11%
466.95
+14.20%
408.88
Allowance For Doubtful Accounts Receivable
-11.30
+10.18%
-12.59
-32.46%
-9.50
-14.95%
-8.27
Other Receivables
75.83
+24.82%
60.75
+10.23%
55.11
+31.67%
41.85
Taxes Receivable
64.98
+140.77%
26.99
+59.03%
16.97
-64.96%
48.43
Inventory
377.76
-1.08%
381.88
+0.42%
380.28
+3.39%
367.82
Raw Materials
96.30
-7.58%
104.19
-2.07%
106.39
+14.65%
92.80
Work In Process
32.59
+2.13%
31.91
+10.07%
28.99
+3.38%
28.04
Finished Goods
248.87
+1.26%
245.78
+0.36%
244.90
-0.84%
246.99
Prepaid Assets
57.90
-1.24%
58.63
+21.20%
48.37
+15.88%
41.74
Current Deferred Assets
73.56
+19.32%
61.65
+14.00%
54.08
+6.51%
50.78
Hedging Assets Current
—
—
—
13.32
Other Current Assets
104.91
-4.46%
109.81
+32.08%
83.14
-6.01%
88.46
Total Non Current Assets
1,936.93
+2.29%
1,893.55
+7.30%
1,764.67
+7.26%
1,645.29
Net PPE
870.61
+4.99%
829.25
+1.42%
817.68
+6.46%
768.09
Gross PPE
1,796.31
+7.93%
1,664.27
+3.86%
1,602.49
+8.72%
1,474.01
Accumulated Depreciation
-925.70
-10.86%
-835.02
-6.40%
-784.82
-11.18%
-705.91
Properties
0.00
0.00
0.00
0.00
Land And Improvements
24.64
+2.70%
23.99
+7.09%
22.40
+0.81%
22.22
Buildings And Improvements
462.39
+3.64%
446.16
+3.27%
432.04
+21.34%
356.05
Machinery Furniture Equipment
991.76
+11.31%
891.00
+6.43%
837.15
+8.36%
772.56
Construction In Progress
68.98
+2.74%
67.14
-15.07%
79.06
-18.76%
97.31
Other Properties
123.23
+6.11%
116.13
+0.55%
115.50
-2.63%
118.62
Leases
125.30
+4.56%
119.84
+3.01%
116.35
+8.48%
107.25
Goodwill And Other Intangible Assets
523.85
+1.37%
516.78
+14.72%
450.46
-1.96%
459.47
Goodwill
414.00
+2.20%
405.10
+10.69%
365.96
+1.15%
361.80
Other Intangible Assets
109.84
-1.64%
111.68
+32.16%
84.50
-13.49%
97.67
Investments And Advances
58.48
+1.32%
57.72
+2.71%
56.19
+1.25%
55.50
Other Investments
58.48
+1.32%
57.72
+2.71%
56.19
+1.25%
55.50
Non Current Accounts Receivable
236.91
+27.71%
185.51
+10.44%
167.96
+12.75%
148.97
Non Current Deferred Assets
27.87
-77.82%
125.63
+17.01%
107.36
-33.90%
162.42
Non Current Deferred Taxes Assets
27.87
-77.82%
125.63
+17.01%
107.36
+94.45%
55.22
Other Non Current Assets
219.22
+22.70%
178.66
+8.27%
165.01
+224.59%
50.84
Total Liabilities Net Minority Interest
1,745.38
+2.78%
1,698.13
-4.35%
1,775.39
-16.96%
2,138.03
Current Liabilities
1,148.81
+7.58%
1,067.92
+12.23%
951.55
-23.00%
1,235.80
Payables And Accrued Expenses
401.04
-4.56%
420.21
+6.33%
395.18
+3.87%
380.46
Payables
199.08
+12.81%
176.46
-10.51%
197.20
+24.20%
158.77
Accounts Payable
110.41
-3.33%
114.21
+3.22%
110.64
+0.38%
110.22
Current Accrued Expenses
201.96
-17.14%
243.75
+23.11%
197.98
-10.70%
221.70
Pensionand Other Post Retirement Benefit Plans Current
212.44
+21.69%
174.58
+0.12%
174.38
+21.95%
142.99
Total Tax Payable
88.67
+42.43%
62.25
-28.08%
86.55
+78.29%
48.55
Current Debt And Capital Lease Obligation
500.07
+13.83%
439.33
+27.42%
344.80
-48.87%
674.41
Current Debt
473.00
+13.21%
417.79
+28.55%
325.00
-50.30%
653.98
Other Current Borrowings
75.00
-55.30%
167.79
+123.72%
75.00
+0.02%
74.98
Current Capital Lease Obligation
27.07
+25.70%
21.54
+8.77%
19.80
-3.05%
20.43
Current Deferred Liabilities
35.26
+4.33%
33.80
-9.13%
37.20
-1.96%
37.94
Current Deferred Revenue
35.26
+4.33%
33.80
-9.13%
37.20
-1.96%
37.94
Total Non Current Liabilities Net Minority Interest
596.56
-5.34%
630.21
-23.50%
823.85
-8.69%
902.23
Long Term Debt And Capital Lease Obligation
475.99
-13.08%
547.62
-24.21%
722.55
-9.18%
795.63
Long Term Debt
374.84
-16.66%
449.79
-27.79%
622.88
-10.30%
694.39
Long Term Capital Lease Obligation
101.15
+3.39%
97.84
-1.84%
99.67
-1.55%
101.24
Tradeand Other Payables Non Current
14.45
-30.85%
20.90
-47.28%
39.64
-19.33%
49.14
Non Current Deferred Liabilities
64.04
+67.43%
38.25
+6.94%
35.77
-8.32%
39.01
Non Current Deferred Revenue
32.18
+19.44%
26.94
-5.59%
28.53
-7.55%
30.86
Non Current Deferred Taxes Liabilities
31.86
+181.69%
11.31
+56.35%
7.24
-11.23%
8.15
Stockholders Equity
1,605.38
+0.63%
1,595.31
+7.46%
1,484.53
+143.87%
608.74
Common Stock Equity
1,605.38
+0.63%
1,595.31
+7.46%
1,484.53
+143.87%
608.74
Capital Stock
10.84
+0.49%
10.78
+0.31%
10.75
+0.30%
10.72
Common Stock
10.84
+0.49%
10.78
+0.31%
10.75
+0.30%
10.72
Share Issued
108.37
+0.49%
107.84
+0.31%
107.51
+0.29%
107.19
Ordinary Shares Number
79.71
-2.32%
81.60
-1.72%
83.03
+0.17%
82.89
Treasury Shares Number
28.66
+9.24%
26.23
+7.18%
24.47
+0.72%
24.30
Additional Paid In Capital
1,826.75
+9.13%
1,673.86
+6.65%
1,569.57
+7.27%
1,463.21
Retained Earnings
6,391.90
+19.87%
5,332.44
+19.98%
4,444.57
+23.48%
3,599.53
Gains Losses Not Affecting Retained Earnings
-68.84
+26.48%
-93.64
-31.51%
-71.21
+8.47%
-77.80
Treasury Stock
6,561.36
+23.01%
5,334.01
+19.20%
4,474.68
+1.88%
4,392.11
Minority Interest
—
—
—
0.00
Other Equity Adjustments
-68.84
+26.48%
-93.64
-31.51%
-71.21
+8.47%
-77.80
Total Equity Gross Minority Interest
1,605.38
+0.63%
1,595.31
+7.46%
1,484.53
+143.87%
608.74
Total Capitalization
1,980.22
-3.17%
2,045.10
-2.96%
2,107.41
+61.72%
1,303.12
Working Capital
265.01
-20.17%
331.98
-38.94%
543.71
+504.77%
-134.33
Invested Capital
2,453.22
-0.39%
2,462.89
+1.25%
2,432.41
+24.29%
1,957.11
Total Debt
976.06
-1.10%
986.95
-7.53%
1,067.35
-27.39%
1,470.03
Net Debt
667.77
+15.27%
579.31
+17.28%
493.95
-60.03%
1,235.82
Capital Lease Obligations
128.22
+7.41%
119.38
-0.08%
119.47
-1.80%
121.66
Net Tangible Assets
1,081.54
+0.28%
1,078.54
+4.30%
1,034.07
+592.75%
149.27
Tangible Book Value
1,081.54
+0.28%
1,078.54
+4.30%
1,034.07
+592.75%
149.27
Foreign Currency Translation Adjustments
—
—
—
-87.69
Line Of Credit
398.00
+59.20%
250.00
+0.00%
250.00
-56.82%
579.00
Minimum Pension Liabilities
—
—
—
-2.78
Non Current Accrued Expenses
42.08
+79.48%
23.44
-9.43%
25.88
+40.33%
18.45
Other Equity Interest
6.09
+3.55%
5.88
+6.42%
5.53
+6.72%
5.18
Unrealized Gain Loss
—
—
—
-0.17
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,181.81
+27.21%
929.00
+2.48%
906.51
+66.95%
542.98
Cash Flow From Continuing Operating Activities
1,181.81
+27.21%
929.00
+2.48%
906.51
+66.95%
542.98
Net Income From Continuing Operations
1,059.46
+19.33%
887.87
+5.07%
845.04
+24.44%
679.09
Depreciation Amortization Depletion
145.18
+11.73%
129.94
+13.08%
114.91
+2.69%
111.90
Depreciation And Amortization
145.18
+11.73%
129.94
+13.08%
114.91
+2.69%
111.90
Other Non Cash Items
5.03
+242.37%
1.47
-26.75%
2.00
-24.23%
2.65
Stock Based Compensation
60.01
-0.47%
60.30
+0.93%
59.74
+20.03%
49.77
Provisionand Write Offof Assets
8.43
+22.75%
6.87
+23.69%
5.55
-4.75%
5.83
Asset Impairment Charge
—
0.25
-83.15%
1.48
-36.74%
2.35
Deferred Tax
131.20
+642.30%
-24.19
+49.92%
-48.31
-37.76%
-35.06
Deferred Income Tax
131.20
+642.30%
-24.19
+49.92%
-48.31
-37.76%
-35.06
Change In Working Capital
-227.51
-70.76%
-133.24
-83.96%
-72.43
+73.52%
-273.53
Change In Receivables
-68.72
-143.01%
-28.28
+47.50%
-53.87
-30.13%
-41.40
Changes In Account Receivables
-68.72
-143.01%
-28.28
+47.50%
-53.87
-30.13%
-41.40
Change In Inventory
-0.79
+97.18%
-28.00
+2.27%
-28.65
+76.46%
-121.73
Change In Payables And Accrued Expense
-8.57
-206.02%
8.09
+1551.71%
-0.56
-116.07%
3.47
Change In Payable
-8.57
-206.02%
8.09
+1551.71%
-0.56
-116.07%
3.47
Change In Account Payable
-8.57
-206.02%
8.09
+1551.71%
-0.56
-116.07%
3.47
Change In Other Working Capital
-149.43
-75.71%
-85.04
-898.53%
10.65
+109.35%
-113.87
Investing Cash Flow
-136.24
+34.20%
-207.06
-65.31%
-125.25
+35.88%
-195.35
Cash Flow From Continuing Investing Activities
-136.24
+34.20%
-207.06
-65.31%
-125.25
+35.88%
-195.35
Net PPE Purchase And Sale
-124.68
-3.10%
-120.92
+9.51%
-133.63
+10.22%
-148.84
Purchase Of PPE
-124.68
-3.10%
-120.92
+9.51%
-133.63
+10.22%
-148.84
Capital Expenditure
-138.23
-5.58%
-130.92
+2.03%
-133.63
+15.87%
-158.84
Net Investment Purchase And Sale
2.74
+76.06%
1.56
-81.40%
8.38
0.00
Sale Of Investment
2.74
+76.06%
1.56
-81.40%
8.38
0.00
Net Business Purchase And Sale
-0.76
+99.03%
-77.70
0.00
+100.00%
-36.51
Purchase Of Business
0.00
+100.00%
-76.69
0.00
+100.00%
-11.51
Net Intangibles Purchase And Sale
-13.55
-35.50%
-10.00
0.00
+100.00%
-10.00
Purchase Of Intangibles
-13.55
-35.50%
-10.00
0.00
+100.00%
-10.00
Financing Cash Flow
-1,164.96
-32.67%
-878.07
-98.66%
-442.00
-19.16%
-370.94
Cash Flow From Continuing Financing Activities
-1,164.96
-32.67%
-878.07
-98.66%
-442.00
-19.16%
-370.94
Net Issuance Payments Of Debt
-30.39
+59.49%
-75.00
+81.44%
-404.00
-193.84%
430.50
Issuance Of Debt
250.00
0.00
0.00
-100.00%
505.50
Repayment Of Debt
-428.38
-471.18%
-75.00
+0.00%
-75.00
+0.00%
-75.00
Long Term Debt Issuance
250.00
0.00
0.00
0.00
Long Term Debt Payments
-428.38
-471.18%
-75.00
+0.00%
-75.00
+0.00%
-75.00
Net Long Term Debt Issuance
-178.38
-137.85%
-75.00
+0.00%
-75.00
+0.00%
-75.00
Short Term Debt Issuance
—
—
—
505.50
Net Short Term Debt Issuance
148.00
0.00
+100.00%
-329.00
-165.08%
505.50
Net Common Stock Issuance
-1,216.96
-45.39%
-837.03
-1063.84%
-71.92
+91.23%
-819.71
Common Stock Payments
-1,216.96
-45.39%
-837.03
-1063.84%
-71.92
+91.23%
-819.71
Repurchase Of Capital Stock
-1,216.96
-45.39%
-837.03
-1063.84%
-71.92
+91.23%
-819.71
Proceeds From Stock Option Exercised
93.36
+109.84%
44.49
-5.40%
47.03
+31.57%
35.75
Net Other Financing Charges
-10.98
-4.24%
-10.53
+19.67%
-13.11
+24.97%
-17.47
Changes In Cash
-119.40
+23.53%
-156.13
-146.02%
339.26
+1555.93%
-23.30
Effect Of Exchange Rate Changes
11.20
+217.52%
-9.53
-548.35%
2.13
+124.70%
-8.61
Beginning Cash Position
288.27
-36.50%
453.93
+303.33%
112.55
-22.09%
144.45
End Cash Position
180.07
-37.53%
288.27
-36.50%
453.93
+303.33%
112.55
Free Cash Flow
1,043.58
+30.76%
798.08
+3.26%
772.88
+101.19%
384.15
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category